TG Therapeutics
TGTX
TGTX
234 hedge funds and large institutions have $1.57B invested in TG Therapeutics in 2023 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 78 increasing their positions, 70 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 39
0.81% more ownership
Funds ownership: 60.05% → 60.86% (+0.81%)
0% less funds holding
Funds holding: 235 → 234 (-1)
Holders
234
Holding in Top 10
5
Calls
$85.5M
Puts
$63.8M
Top Buyers
| 1 | +$47M | |
| 2 | +$29.8M | |
| 3 | +$18.8M | |
| 4 |
Morgan Stanley
New York
|
+$12.8M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$11.9M |
Top Sellers
| 1 | -$26M | |
| 2 | -$25.4M | |
| 3 | -$18.2M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$16.8M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$13.5M |